Telmisartan+Amlodipine
Telam contains two active substances - telmisartan and amlodipine. Both substances work by lowering blood pressure.
Telam is used inthe treatment of high blood pressure:
Untreated high blood pressure can lead to damage to blood vessels in several organs, which can increase the risk of serious complications such as heart attack, heart failure or kidney failure, stroke or blindness. Usually, there are no symptoms of high blood pressure before organ damage occurs. Therefore, regular blood pressure measurements are important to confirm that the values are normal.
If you are in any of the above situations, you should discuss this with your doctor before taking Telam.
Before starting to take Telam, you should consult your doctor if you have or have had any of the following disorders or diseases:
Before starting to take Telam, you should discuss this with your doctor:
In the event of planned surgery (surgical procedure) or anesthesia, you should inform your doctor that you are taking Telam.
If you experience abdominal pain, nausea, vomiting, or diarrhea after taking Telam, you should discuss this with your doctor. Your doctor will decide on further treatment. You should not stop taking Telam on your own.
Telam should not be used in children and adolescents under 18 years of age.
You should tell your doctor or pharmacist about all the medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Your doctor may recommend changing the dose of these medicines or taking other precautions. In some cases, it may be necessary to stop taking one of these medicines.
This applies in particular to the simultaneous use of the following medicines with Telam:
As with other blood pressure-lowering medicines, the effect of Telam may be reduced when taken with NSAIDs (non-steroidal anti-inflammatory drugs, e.g., acetylsalicylic acid or ibuprofen) or corticosteroids.
Telam may enhance the blood pressure-lowering effect of other antihypertensive medicines or medicines that may lower blood pressure (e.g., baclofen, amifostine, neuroleptics, and antidepressants).
The blood pressure-lowering effect may be enhanced by alcohol. This may be felt as dizziness when standing up.
While taking Telam, you should not drink grapefruit juice or eat grapefruits, as grapefruit and grapefruit juice may lead to increased levels of the active substance amlodipine in the blood and enhance the blood pressure-lowering effect of Telam.
Pregnancy
You should inform your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant. Your doctor will usually recommend stopping Telam before planned pregnancy and switching to another medicine instead of Telam. Telam should not be used in early pregnancy and must not be used after the third month of pregnancy, as it may seriously harm the baby.
Breastfeeding
It has been shown that small amounts of amlodipine pass into human milk.
You should inform your doctor if you are breastfeeding or plan to breastfeed. Telam should not be used during breastfeeding, especially in newborns or premature babies. Your doctor may recommend another medicine.
Some patients treated for high blood pressure may experience side effects such as dizziness, drowsiness, or fainting. If you experience such side effects, you should not drive or operate machinery.
Telam contains less than 1 mmol of sodium (23 mg) per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be taken exactly as prescribed by your doctor. If you are unsure, you should consult your doctor or pharmacist.
The recommended dose is one tablet per day.
The maximum recommended dose is one tablet of 80 mg telmisartan + 10 mg amlodipine per day.
You should try to take the tablet at the same time every day.
The Telam tablet should be removed from the blister pack immediately before taking.
Telam can be taken with or without food. The tablets should be swallowed with a small amount of water or another non-alcoholic drink (except grapefruit juice).
If you have liver function disorders, the usual dose should not exceed one tablet of 40 mg+5 mg or one tablet of 40 mg+10 mg per day.
If you have taken too many tablets, you should contact your doctor, pharmacist, or go to the emergency department of the nearest hospital immediately. You may experience low blood pressure and a rapid heart rate. Slow heart rate, dizziness, worsening of kidney function, including kidney failure, severe and prolonged low blood pressure, including shock and death, have also been reported.
Up to 24-48 hours after taking the medicine, shortness of breath due to excess fluid accumulation in the lungs (pulmonary edema) may occur.
If you miss a dose, you should take it as soon as possible and continue taking the medicine as prescribed by your doctor. If you miss a tablet one day, you should take the usual dose of Telam the next day at the usual time.
You should not take a double dose to make up for the missed dose.
It is important to take Telam every day, unless your doctor tells you to stop. If you feel that the effect of Telam is too strong or too weak, you should consult your doctor or pharmacist.
If you have any further doubts about the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following symptoms, you should contact your doctor immediately:
Septicemia (often referred to as blood poisoning, being an infection of the entire body, with high fever and very poor general condition), sudden swelling of the skin and mucous membranes (angioedema).
These side effects are rare (may occur in less than 1 in 1000 patients), but are very serious, and in such cases, you should stop taking the medicine and contact your doctor immediately. If left untreated, these side effects can be fatal. The frequency of septicemia is increased in patients taking telmisartan monotherapy; however, it cannot be ruled out in the case of Telam therapy.
Common(may occur in less than 1 in 10 patients):
Dizziness, swelling of the ankles.
Uncommon(may occur in less than 1 in 100 patients):
Drowsiness, migraine, headache, tingling or numbness of the hands or feet, feeling of spinning, slow heart rate, palpitations (awareness of heartbeat), low blood pressure (hypotension), dizziness when standing up (orthostatic hypotension), sudden flushing (especially of the face), cough, stomach pain (abdominal pain), diarrhea, nausea, itching, joint pain, muscle cramps, muscle pain, erectile dysfunction, weakness, chest pain, swelling (edema), increased liver enzyme activity.
Rare(may occur in less than 1 in 1000 patients):
Urinary tract infections, feeling of sadness (depression), anxiety, insomnia, fainting, nerve damage in the hands or feet, decreased sensitivity to touch, taste disorders, tremors, vomiting, gum hypertrophy, abdominal complaints, dryness of the mucous membranes of the mouth, rash (skin disorder), redness of the skin, rash, back pain, leg pain, nocturia, malaise, increased uric acid levels in the blood.
Very rare(may occur in less than 1 in 10,000 patients):
Progressive scarring of lung tissue (interstitial lung disease [mainly interstitial pneumonia and eosinophilic pneumonia]).
The following side effects have been reported with telmisartan or amlodipine; these side effects may also occur with Telam:
Telmisartan
Patients taking telmisartan alone have reported the following additional side effects:
Uncommon(may occur in less than 1 in 100 patients):
Urinary tract infections, upper respiratory tract infections (e.g., sore throat, sinusitis, common cold), anemia, high potassium levels in the blood, shortness of breath, bloating, increased sweating, kidney damage, including sudden cessation of kidney function, increased creatinine levels.
Rare(may occur in less than 1 in 1000 patients):
Increased white blood cell count of a certain type (eosinophilia), low platelet count (thrombocytopenia), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), low blood sugar levels (in diabetic patients), vision disturbances, rapid heart rate, gastritis, abnormal liver function, hives, allergic rash, tendonitis, flu-like syndrome (e.g., muscle pain, general poor condition), decreased hemoglobin levels (a protein in the blood), increased phosphocreatine kinase activity in the blood, low sodium levels.
Most cases of abnormal liver function or liver damage after the introduction of telmisartan to the market occurred in Japanese patients. The likelihood of this side effect is higher in Japanese patients.
Unknown(frequency cannot be estimated from the available data):
Angioedema of the intestine - after the use of similar products, angioedema of the intestine has been reported with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Amlodipine
Patients taking amlodipine alone have reported the following additional side effects:
Common(may occur in less than 1 in 10 patients):
Changes in bowel movements, diarrhea, constipation, vision disturbances, double vision, swelling of the ankles.
Uncommon(may occur in less than 1 in 100 patients):
Mood changes, vision disturbances, ringing in the ears, shortness of breath, sneezing or runny nose, hair loss, unusual bruising and bleeding (platelet dysfunction), skin discoloration, increased sweating, difficulty urinating, increased frequency of urination, especially at night, breast enlargement in men, pain, weight gain, weight loss.
Rare(may occur in less than 1 in 1000 patients):
Confusional state.
Very rare(may occur in less than 1 in 10,000 patients):
Decreased white blood cell count (leukopenia), low platelet count (thrombocytopenia), allergic reaction (e.g., rash, itching, difficulty breathing, wheezing, swelling of the face or low blood pressure), high blood sugar levels, uncontrolled muscle twitching or cramps, heart attack, arrhythmias, vasculitis, pancreatitis, gastritis, liver disease, jaundice, increased liver enzyme activity with jaundice, sudden swelling of the skin and mucous membranes (angioedema), severe skin reactions, hives, severe allergic reactions with blistering of the skin and mucous membranes (Stevens-Johnson syndrome), increased skin sensitivity to sunlight, increased muscle tension.
Unknown(frequency cannot be estimated from the available data):
Severe allergic reactions with blistering of the skin and mucous membranes (toxic epidermal necrolysis).
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton or blister pack after: EXP. The expiry date refers to the last day of the month stated.
The inscription on the packaging after the abbreviation EXP indicates the expiry date, and after the abbreviation Lot/LOT, it indicates the batch number.
Store in the original packaging to protect from light. The Telam tablet should be removed from the blister pack immediately before taking.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Telam 40 mg+5 mg tablets: two-layer tablets, white or almost white on one side, pink on the other side, with slight speckling allowed on the pink side, oblong, (12.2 - 12.8 mm x 5.7 - 6.3 mm), biconvex.
Telam 40 mg+10 mg tablets: two-layer tablets, white or almost white on one side, yellow on the other side, with slight speckling allowed on the yellow side, oblong, (12.2 - 12.8 mm x 5.7 - 6.3 mm), biconvex.
Telam 80 mg+5 mg tablets: two-layer tablets, white or almost white on one side, pink on the other side, with slight speckling allowed on the pink side, oblong, (14.7 - 15.3 mm x 7.0 - 7.6 mm), biconvex.
Telam 80 mg+10 mg tablets: two-layer tablets, white or almost white on one side, yellow on the other side, with slight speckling allowed on the yellow side, oblong, (14.7 - 15.3 mm x 7.0 - 7.6 mm), biconvex.
Telam is available in a carton containing 14, 28, 30, 56, 90, 98 tablets.
Not all pack sizes may be marketed.
Polpharma S.A.
Pelplińska 19
83-200 Starogard Gdański
Phone: +48 22 364 61 01
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.